Emergent BioSolutions (EBS) Other Working Capital Changes (2010 - 2026)
Emergent BioSolutions (EBS) posted quarterly Other Working Capital Changes of $3.2 million for Q1 2026, up 1166.67% year-over-year from $252631.6 in Q1 2025, and down 21.95% quarter-over-quarter from $4.1 million in Q4 2025.
Emergent BioSolutions (EBS) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Emergent BioSolutions' Other Working Capital Changes history runs 10 years deep, the most recent figure standing at $3.2 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 1166.67% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $8.7 million (up 1066.67% YoY), while the FY2025 annual figure was $5.2 million, up 125.62% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $3.2 million, down from $4.1 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $16.6 million in Q1 2022, with the low at -$166.0 million in Q2 2024.
- The 5-year median for Other Working Capital Changes is $2.1 million (2025), against an average of -$10.8 million.
- The sharpest annual moves came in 2023 and 2026: Other Working Capital Changes tumbled 320.0% in 2023, then soared 1166.67% in 2026.
- Emergent BioSolutions' Other Working Capital Changes stood at $5.4 million in 2022, then decreased by 24.07% to $4.1 million in 2023, then sank by 136.59% to -$1.5 million in 2024, then jumped by 373.33% to $4.1 million in 2025, then retreated by 21.95% to $3.2 million in 2026.
- Business Quant data shows EBS's Other Working Capital Changes at $3.2 million in Q1 2026, $4.1 million in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 100,000.00 |
| Jun 30, 2026 | 100,000.00 |
| Jun 30, 2026 | 100,000.00 |
| Mar 31, 2026 | 500,000.00 |
| Mar 31, 2026 | 500,000.00 |
| Mar 31, 2026 | 500,000.00 |
| Dec 31, 2025 | 15.40 Mn |
| Dec 31, 2025 | 15.40 Mn |
| Dec 31, 2025 | 15.40 Mn |
| Sep 30, 2025 | 2.10 Mn |
| Sep 30, 2025 | 2.10 Mn |
| Sep 30, 2025 | 2.10 Mn |
| Jun 30, 2025 | -19.70 Mn |
| Jun 30, 2025 | -19.70 Mn |
| Jun 30, 2025 | -19.70 Mn |
| Mar 31, 2025 | -9.50 Mn |
| Mar 31, 2025 | -9.50 Mn |
| Mar 31, 2025 | -9.50 Mn |
| Dec 31, 2024 | -23.60 Mn |
| Dec 31, 2024 | -23.60 Mn |